塩野義製薬が1600億円でJT子会社「鳥居薬品」買収 花粉症に強み JTは撤退へ by | May 7, 2025 | ニュース | 0 comments Post Content Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.